Metabolic syndrome: an appraisal of the pro-inflammatory and procoagulant status

被引:103
作者
Devaraj, S
Rosenson, RS
Jialal, I
机构
[1] Univ Calif Davis, Med Ctr, Lab Atherosclerosis & Metab Res, Sacramento, CA 95817 USA
[2] Northwestern Univ, Feinberg Sch Med, Dept Med, Div Cardiol,Prevent Cardiol Ctr, Chicago, IL 60611 USA
[3] Northwestern Univ, Feinberg Sch Med, Dept Prevent Med, Div Cardiol,Prevent Cardiol Ctr, Chicago, IL 60611 USA
关键词
D O I
10.1016/j.ecl.2004.03.008
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Inflammation and hypercoagulability predispose to atherothrombosis and seem to be important features of the metabolic syndrome. The most convincing evidence is the association with increased levels of C-reactive protein. The hemostatic abnormality that has been most consistently associated with insulin resistance is an elevated plasminogen activator inhibitor-1 level. In contrast, markers of hypercoagulability have been associated inconsistently with hyperinsulinemia and glucose intolerance. Fibrinogen clusters with inflammatory factors, which suggests involvement of adipose tissue-generated inflammatory cytokines. Elevated von Willebrand's factor and factor VIII levels aggregate with indicators of endothelial injury, whereas vitamin K-dependent coagulation proteins correlate with triglyceride levels.
引用
收藏
页码:431 / +
页数:24
相关论文
共 127 条
  • [61] Association of adiponectin mutation with type 2 diabetes - A candidate gene for the insulin resistance syndrome
    Kondo, H
    Shimomura, I
    Matsukawa, Y
    Kumada, M
    Takahashi, M
    Matsuda, M
    Ouchi, N
    Kihara, S
    Kawamoto, T
    Sumitsuji, S
    Funahashi, T
    Matsuzawa, Y
    [J]. DIABETES, 2002, 51 (07) : 2325 - 2328
  • [62] ELEVATED FIBRINOGEN AND PLASMINOGEN-ACTIVATOR INHIBITOR (PAI-1) IN HYPERTENSION ARE RELATED TO METABOLIC RISK-FACTORS FOR CARDIOVASCULAR-DISEASE
    LANDIN, K
    TENGBORN, L
    SMITH, U
    [J]. JOURNAL OF INTERNAL MEDICINE, 1990, 227 (04) : 273 - 278
  • [63] Insulin resistance and adiposity correlate with acute-phase reaction and soluble cell adhesion molecules in type 2 diabetes
    Leinonen, E
    Hurt-Camejo, E
    Wiklund, O
    Hultén, LM
    Hiukka, A
    Taskinen, MR
    [J]. ATHEROSCLEROSIS, 2003, 166 (02) : 387 - 394
  • [64] Elevated C-reactive protein -: Another component of the atherothrombotic profile of abdominal obesity
    Lemieux, I
    Pascot, A
    Prud'homme, D
    Alméras, N
    Bogaty, P
    Nadeau, A
    Bergeron, J
    Després, JP
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2001, 21 (06) : 961 - 967
  • [65] Libby P, 2002, NATURE, V420, P868, DOI [10.1038/nature01323, 10.1161/ATVBAHA.108.179705]
  • [66] PAI-1 polymorphisms modulate phenotypes associated with the metabolic syndrome in obese and diabetic Caucasian population
    Lopes, C
    Dina, C
    Durand, E
    Froguel, P
    [J]. DIABETOLOGIA, 2003, 46 (09) : 1284 - 1290
  • [67] LOWE GDO, 1980, THROMB HAEMOSTASIS, V42, P1503
  • [68] MANSFIELD MW, 1995, THROMB HAEMOSTASIS, V74, P842
  • [69] Adiponectin and metabolic syndrome
    Matsuzawa, Y
    Funahashi, T
    Kihara, S
    Shimomura, I
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2004, 24 (01) : 29 - 33
  • [70] Interleukin-6 as a central mediator of cardiovascular risk associated with chronic inflammation, smoking, diabetes, and visceral obesity: down-regulation with essential fatty acids, ethanol and pentoxifylline
    McCarty, MF
    [J]. MEDICAL HYPOTHESES, 1999, 52 (05) : 465 - 477